Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Bicara Therapeutics Inc. | 204,141 | reported | 15 May 2026 | tx 41+413,000−251,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 May 2026 | EXERCISE | Bicara Therapeutics Inc. | 8,000 | 3.79 USD | 10b5-1 |
| 15 May 2026 | SALE | Bicara Therapeutics Inc. | 8,000 | 20.29 USD | 10b5-1 |
| 15 May 2026 | SALE | Bicara Therapeutics Inc. | 4,500 | 20.29 USD | 10b5-1 |
| 15 May 2026 | EXERCISE | Bicara Therapeutics Inc. | 8,000 | 0.00 USD | 10b5-1deriv |
| 16 Mar 2026 | SALE | Bicara Therapeutics Inc. | 8,000 | 19.66 USD | |
| 16 Mar 2026 | SALE | Bicara Therapeutics Inc. | 4,500 | 19.66 USD | |
| 16 Mar 2026 | EXERCISE | Bicara Therapeutics Inc. | 8,000 | 3.79 USD | |
| 16 Mar 2026 | EXERCISE | Bicara Therapeutics Inc. | 8,000 | 0.00 USD | deriv |
| 03 Mar 2026 | SALE | Bicara Therapeutics Inc. | 12,892 | 18.16 USD | |
| 03 Mar 2026 | EXERCISE | Bicara Therapeutics Inc. | 12,892 | 3.79 USD | |
| 03 Mar 2026 | SALE | Bicara Therapeutics Inc. | 4,500 | 18.16 USD | |
| 03 Mar 2026 | EXERCISE | Bicara Therapeutics Inc. | 12,892 | 0.00 USD | deriv |
| 25 Feb 2026 | EXERCISE | Bicara Therapeutics Inc. | 3,108 | 3.79 USD | |
| 25 Feb 2026 | SALE | Bicara Therapeutics Inc. | 3,108 | 18.04 USD | |
| 25 Feb 2026 | SALE | Bicara Therapeutics Inc. | 523 | 18.04 USD | |
| 25 Feb 2026 | EXERCISE | Bicara Therapeutics Inc. | 3,108 | 0.00 USD | deriv |
| 02 Feb 2026 | GRANT_AWARD | Bicara Therapeutics Inc. | 300,000 | 0.00 USD | deriv |
| 22 Jan 2026 | SALE | Bicara Therapeutics Inc. | 3,828 | 18.10 USD | |
| 15 Jan 2026 | SALE | Bicara Therapeutics Inc. | 149 | 18.02 USD | anomaly |
| 26 Dec 2025 | EXERCISE | Bicara Therapeutics Inc. | 25,000 | 4.44 USD | |
| 26 Dec 2025 | EXERCISE | Bicara Therapeutics Inc. | 25,000 | 0.00 USD | deriv |
| 15 Dec 2025 | SALE | Bicara Therapeutics Inc. | 4,500 | 18.68 USD | |
| 15 Dec 2025 | SALE | Bicara Therapeutics Inc. | 8,000 | 18.68 USD | |
| 15 Dec 2025 | EXERCISE | Bicara Therapeutics Inc. | 8,000 | 3.79 USD | |
| 15 Dec 2025 | EXERCISE | Bicara Therapeutics Inc. | 8,000 | 0.00 USD | deriv |